Butanedione → N-(2,2-dimethoxyethyl)-2-(2-pyrrolidin-1-ylethyl)-2H-indazol-5-amine

HRID 1825842ノート

反応式

HRID 1825842 の反応式
[N:1]1([CH2:6][CH2:7][N:8]2[CH:16]=[C:15]3[C:10]([CH:11]=[CH:12][C:13]([NH2:17])=[CH:14]3)=[N:9]2)[CH2:5][CH2:4][CH2:3][CH2:2]1.CC(=O)[C:20](C)=[O:21].[BH-](OC(C)=O)(OC(C)=O)OC(C)=O.[Na+].[CH2:38]1[CH2:42][O:41][CH2:40]C1>CCOCC>[CH3:20][O:21][CH:42]([O:41][CH3:40])[CH2:38][NH:17][C:13]1[CH:12]=[CH:11][C:10]2[C:15](=[CH:16][N:8]([CH2:7][CH2:6][N:1]3[CH2:2][CH2:3][CH2:4][CH2:5]3)[N:9]=2)[CH:14]=1

参加物

6

実験手順

To a solution of 2-(2-pyrrolidin-1-ylethyl)-2H-indazol-5-amine (1.14 g, 0.497 mmol) in 62 mL of dry THF was added 2.04 mL of dimethyl glyoxal in ether (45% glyoxal by weight). A slurry of NaBH(OAc)3 (1.66 g, 7.83 mmol) in THF (10 mL) was slowly added via addition funnel over 60 minutes, and the mixture stirred at room temperature for 12 hours, after which an additional equivalent of NaBH(OAc)3 was added. After an additional 12 hours, the mixture was quenched with saturated NaHCO3, filtered, and the solvents removed under reduced pressure. The residue was purified via column chromatography eluting with 5–15% Et3N in EtOAc to provide 650 mg (2.04 mmol) of the title compound. 1H NMR (300 MHz, DMSO-D6) δ ppm 1.55–1.73 (m, 4 H) 2.39–2.49 (m, 4 H) 2.85–2.96 (m, 2 H) 3.05–3.20 (m, 2 H) 3.28–3.33 (m, 6 H) 4.31–4.45 (m, 2 H) 4.48–4.61 (m, 1 H) 5.14–5.32 (m, 1 H) 6.37–6.50 (m, 1 H) 6.74–6.91 (m, 1 H) 7.21–7.42 (m, 1 H) 7.83–8.02 (m, 1 H); MS (ESI) m/z 319 [M+H]+.

後処理

  1. waitAfter an additional 12 hours
  2. customthe mixture was quenched with saturated NaHCO3
  3. filtrationfiltered
  4. customthe solvents removed under reduced pressure
  5. customThe residue was purified via column chromatography
  6. washeluting with 5–15% Et3N in EtOAc

出典と根拠

ORDレコード
ord-ce014252c8e94e4dbd436756db6da13e
出典データセット
uspto-grants-2006_05
特許番号
US07049307B2

反応ノート

読み込み中…